Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Stock Report

| More

HCG Cancer Hospital Bengaluru successfully operates on a patient with 'Congenital Hemophilia'

Posted On: 2021-04-20 11:06:32 (Time Zone: UTC)

HCG Cancer Hospital has successfully treated a 49-year-old young man suffering from Hemophilia, a rare life-threatening blood disorder who had developed a massive tumor near his abdomen. Dr. Sachin Jadhav along with Dr. Pramod Chinder and Dr Indushekar's team successfully performed the procedure. Due to his pre-existing Hemophilia, the procedure to remove the tumor was extremely challenging. The entire treatment cost was borne by Govt. of India with the support of Govt. of Karnataka and ESI Hospital routed through Hemophilia Society Bangalore Chapter.

Satish (name changed) a patient from Kengeri was presented with a massive tumor near his abdomen at HCG Cancer Hospital Bengaluru. He was suffering from a rare condition 'Congenital Hemophilia' which is caused by a deficiency in clotting of the blood. This is a rare, chronic, inherited bleeding disorder caused by the deficiency of clotting factors VIII (hemophilia A) or IX (hemophilia B), and over time may cause damage to the joint's leading to recurrent joint bleeding. This is gender-linked and predominantly affects males.

In the case of Satish, he had severe hemophilia, usually 40% factor is required for the human body to function whereas he had less than 1%. At the age of 12 he was diagnosed with this disease and had lost his two brothers due to the same condition. Due to this condition his life was also under threat and the treatment for hemophilia is lifelong.

In 2018 he developed a small tumor on his back for which he underwent surgery. In 2020 the same tumor developed and started growing. This tumor was due to internal bleeding and blood kept on accumulating forming an enormous 29cms swelling in his left abdomen. Satish consulted other private hospitals that rejected his case due to the severity. Later he decided to seek medical advice at ESI after which he was referred to HCG Cancer Hospital Bengaluru.

The swelling was like an ice burg, the visible part was just 5cms but the MRI revealed that the swelling was spreading internally very massively & the right side of his abdomen was almost replaced by blood. Satish initially consulted an orthopedic doctor who later referred him to Dr. Sachin Jadhav. When Dr. Sachin analyzed his case, he immediately proceeded with further evaluation.

As per Dr. Sachin Jadhav, Group Head of Hematology and Bone Marrow Transplant, HCG Cancer Hospital, "This was an extremely challenging and complex case as the patient was suffering from a rare condition 'Congenital Hemophilia'. In people with hemophilia, there is a deficiency of plasma products which helps in stopping blood loss. Factor 8 and factor 9 help in clotting the blood so that they do not suffer excess blood loss. In a hemophilic patient, this product is absent. So, in case of an injury, these patients may experience excessive bleeding or may even bleed to death. Factor replacement is created to artificially supplement what is not there in the body. Once these factors are diagnosed and the patient is known for a factor deficiency, then according to their bleeding tendencies, the factors are replaced so that the patient does not bleed abnormally."

In the case of Satish, his swelling was made of blood which is called as pseudo tumour. The tumour had arteries feeding into it. When a hemophilia patient is given with factor 8, inhibitors may developed. Patient with hemophilia A or B can develop inhibitors, which prevent their factor 8 or 9 replacement treatment from working to form a clot to stop bleeding.

On evaluation Satish was found to have inhibitors. Hence he needed a special medicine called FEIBA(Factor eight Inhibitor bypass activity) during surgery. Another challenge was that the drug was not available in India and had to be shipped from abroad.

Before proceeding with the massive surgery to remove the pseudotumor, a procedure called embolization had to be performed. Embolization is performed by placing a small catheter inside the blood vessels that supply the area that is bleeding. Carefully navigating the catheter, under image guidance, to the safest and farthest point, a variety of different materials can then be used to block the bleeding vessels. Dr. Indushekar and team worked on this process. This reduced the risk of excessive bleeding during the surgery which was planned for the next day. The next day the surgery was performed by Dr. Pramod Chinder and team which lasted for 7 hours.

Dr. Pramod S Chinder, Director & Head of the Department- Orthopedic Oncology, HCG Cancer Hospital says, "This is the biggest tumor we have operated of this hemophilia condition. It was a huge tumor that kept on bleeding to itself and led to the decrease in hemoglobin which was highly challenging while operating the patient. The bleeding was uncontrollable and was threat to life of the patient. We were extra cautious and prepared during the surgery to face any complications. With the support of Dr. Sachin and multidisciplinary team approach we were able to successfully perform the surgery."

Post the surgery the patient was kept under observation for a couple of days and two drains were put, to keep a count on the blood loss. The patient recovered well without any complications and has been discharged from the hospital. He is now leading a normal life.

Speaking about the complexity of the case Mr. Pemroop Alva, General Secretary, Hemophilia Society Bangalore Chapter said "Mr. Satish's case very was complicated and we have handled very few cases like his successfully in the past. We are grateful towards Dr. Sachin and the entire team of HCG Cancer Hospital Bengaluru, for taking up this case and handling it successfully. We are truly impressed by the multidisciplinary focused approach adopted by the team. We are confident and believe that together we will make our Hemophilia community better. Wishing more successful endeavors to the entire team".

Mr. Satish, the patient said "I would like to thank the entire team of specialists at HCG Cancer Hospital Bangalore, without them my life would not be the same. I had no hope for the future. But the doctors here at HCG gave me the best care and treatment. This is a second life for me, and I am extremely happy to be leading a better life".

Shares of HealthCare Global Enterprises Ltd was last trading in BSE at Rs.169.2 as compared to the previous close of Rs. 167.25. The total number of shares traded during the day was 6487 in over 306 trades.

The stock hit an intraday high of Rs. 170.8 and intraday low of 163.65. The net turnover during the day was Rs. 1089675.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Sun Pharma Advanced Research Company Limited board to consider Q4, FY21 results on May 17, 2021

Maruti Suzuki boosting manufacturing of Oxygen PSA generator plants

Kriti Industries India Ltd board to approve Q4, FY21 results, dividend on May 15, 2021

Sun Pharma Advanced Research Company Limited board to consider fund raising proposal on May 12, 2021

Texel Industries Ltd board approves rights issue to raise Rs. 20 crores

Thyrocare Technologies Ltd Q4FY21 consolidated PAT up at Rs. 37.75 crore

Just Dial Ltd board to consider Q4, FY21 results on May 14, 2021

Thyrocare Technologies Ltd board recommends dividend of Rs. 15

Jubilant Pharma wins over Bracco's Legal appeals in the United States Court of Appeals

IDFC First Bank Ltd reports Rs. 136.92 crore consolidated PAT in Q4FY21

Indag Rubber Ltd board recommends final dividend of Rs. 1.50

HDFC to sell 0.62% stake in HDFC ERGO

The Federal Bank Limited board to consider Q4, FY21 results, dividend on May 17, 2021

TTK Prestige Ltd to shutdown Coimbatore, Hosur plants due to lockdown announced by TN Government

Maruti Suzuki extends maintenance shutdown till May 16, 2021

T T Limited announces cancellation of MOU for sale of Spinning Mills

Indag Rubber Ltd posts Rs. 1.46 crore consolidated PAT in Q4FY21

Yaarii Digital Integrated Services Limited Q4FY21 consolidated loss at Rs. 11.72 crore

SORIL Infra Resources Ltd posts consolidated PAT of Rs. 0.40 crore in Q4FY21

Triveni Turbine Ltd approves reappointment of Mr. Nikhil Sawhney as MD

DCB Bank Ltd Q4FY21 net profit slips QoQ to Rs. 77.91 crore

Avenue Supermarts Ltd reports earnings for Q4, FY21

Welspun India Ltd Board to consider FY21 results, Dividend & Buyback of Equity Shares on May 14, 2021

Vardhman Acrylics Ltd Q4FY21 PAT jumps to Rs. 22.93 crore

Bandhan Bank Ltd Board recommends Dividend of Rs. 1 for FY21

Seshasayee Paper and Boards Ltd Board approves Dividend of Rs. 2.50

Nitin Spinners Ltd Board recommends Dividend of Rs. 1.50

R.S. Software (India) Ltd board to approve Q4, FY21 results on May 19, 2021

Aarti Drugs Ltd board to consider Q4, FY21 results on May 15, 2021

Lotus Eye Hospital and Institute Ltd to operate with minimum staff due to second wave Covid-19

Avenue Supermarts Ltd posts Rs. 413.88 crores consolidated PAT in Q4 FY2020-21

Bandhan Bank Ltd reports Rs. 103.03 crore net profit in Q4 FY2020-21

CSB Bank Ltd Q4FY21 net profit at Rs. 42.89 crore

Seshasayee Paper and Boards Ltd Q4FY21 consolidated net profit rises to Rs. 63.61 crore

Nitin Spinners Ltd posts jump in Q4FY21 PAT to Rs. 42.85 crore

Aditya Birla Capital Ltd board to approve FY21 results on May 14, 2021

Quick Heal Technologies Ltd board to announce dividend, Q4, FY21 results on May 15, 2021

Suraj Ltd board to consider Q4, FY21 results on May 17, 2021

AYM Syntex Ltd board to consider Q4, FY21 results on May 15, 2021

ICRA reaffirms rating of V-Guard Industries Limited

SKP Securities Ltd posts Rs. 1.18 crore PAT in Q4FY21

Ultratech Cement Ltd posts Rs. 1775.23 crores consolidated PAT in Q4FY21

Reliance Power Limited reports earnings for FY21

S.P. Apparels Limited closes retail outlets temporarily

UltraTech Cement Limited board recommends dividend of Rs. 37

Sutlej Textiles & Industries Ltd Board recommends Dividend of Rs. 0.30

Cholamandalam Investment and Finance Company Limited board recommends final dividend of Rs. 0.70

Navin Fluorine International Ltd board recommends final dividend of Rs. 6

Everest Industries Limited appoints Mr. Pramod Nair as CFO

CAMS - India's Largest RTA - lists on NSE

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020